Newly spun off Qnity proves it’s an AI force that investors should not ignore
Qnity Electronics on Thursday reported strong fourth-quarter results alongside rosy guidance, solidifying its reputation as an under-the-radar beneficiary of the
Read More
club earnings
Nvidia keeps the AI party alive with a booming quarter and even better outlook
Nvidia on Wednesday delivered strong quarterly results to cap off its fiscal year, outdone only by the chip giant’s outlook
Read More
AI disruption didn’t show up in Salesforce results. But the fears are hard to shake
Salesforce on Wednesday evening delivered better-than-expected 2026 fourth-quarter results as its Agentforce artificial intelligence platform became increasingly embedded across the
Read More
We’re boosting our price target on retail stock TJX after another knockout quarter
Shares of TJX Companies were flat on Wednesday despite the off-price retailer delivering another fantastic quarterly report. Conservative guidance, while
Read More
Home Depot delivers its best quarter of 2025 — this year should be even better
Home Depot shares are up 3% after the retailer reported beats on sales, earnings, and same-store sales. While those headline
Read More
Texas Roadhouse gets a pass from Wall Street. What’s next might be out of its control
Texas Roadhouse missed Street estimates on both the top and bottom lines in the fourth quarter as high beef prices
Read More
We cut our Palo Alto price target, but view the post-earnings drop as an opportunity
Palo Alto Networks on Tuesday evening delivered a strong quarter. But in a market with no room for error, the
Read More
Cisco shares slide after earnings fail to wow the Street. Here’s our plan for the stock
Cisco Systems shares fell Wednesday evening despite the networking company delivering a beat and raise. The results were solid but
Read More
Our DuPont thesis is working according to plan. We’re raising our price target
A newly slimmed-down DuPont reported strong quarterly results on Tuesday, sending its stock to a new all-time high. Our long-running
Read More
We’re increasing our price target on Bristol Myers after earnings and guidance top forecasts
Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast that was
Read More